CL2012000013A1 - Compuestos derivados de 4-{3-[3-(4-trifluorometil-fenil)ureido]-5-fluoro-bencilamino}-1h-pirazol-3-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso como moduladores de la actividad de las proteinas quinasa para el tratamiento del cancer. - Google Patents
Compuestos derivados de 4-{3-[3-(4-trifluorometil-fenil)ureido]-5-fluoro-bencilamino}-1h-pirazol-3-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso como moduladores de la actividad de las proteinas quinasa para el tratamiento del cancer.Info
- Publication number
- CL2012000013A1 CL2012000013A1 CL2012000013A CL2012000013A CL2012000013A1 CL 2012000013 A1 CL2012000013 A1 CL 2012000013A1 CL 2012000013 A CL2012000013 A CL 2012000013A CL 2012000013 A CL2012000013 A CL 2012000013A CL 2012000013 A1 CL2012000013 A1 CL 2012000013A1
- Authority
- CL
- Chile
- Prior art keywords
- benzylamino
- ureido
- carboxamide
- pyrazole
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos derivados de 4-{3-[3-(4-trifluorometil-fenil)-ureido]-5-fluoro-bencilamino}-1h-pirazol-3-carboxamida; procedimiento de preparación; medicamento que los comprende; composición farmacéutica que los comprende; compuesto intermediario; y su uso para el tratamiento del cáncer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0903270A FR2947546B1 (fr) | 2009-07-03 | 2009-07-03 | Derives de pyrazoles, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012000013A1 true CL2012000013A1 (es) | 2012-09-14 |
Family
ID=41695643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012000013A CL2012000013A1 (es) | 2009-07-03 | 2012-01-03 | Compuestos derivados de 4-{3-[3-(4-trifluorometil-fenil)ureido]-5-fluoro-bencilamino}-1h-pirazol-3-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso como moduladores de la actividad de las proteinas quinasa para el tratamiento del cancer. |
Country Status (31)
Country | Link |
---|---|
US (1) | US8367715B2 (es) |
EP (1) | EP2448924B1 (es) |
JP (1) | JP5680640B2 (es) |
KR (1) | KR20120037967A (es) |
CN (1) | CN102471280B (es) |
AR (1) | AR077371A1 (es) |
AU (1) | AU2010267824A1 (es) |
BR (1) | BR112012000104A2 (es) |
CA (1) | CA2767096A1 (es) |
CL (1) | CL2012000013A1 (es) |
CO (1) | CO6480992A2 (es) |
CR (1) | CR20110701A (es) |
DO (1) | DOP2012000001A (es) |
EA (1) | EA020364B1 (es) |
EC (2) | ECSP12011569A (es) |
FR (1) | FR2947546B1 (es) |
HK (1) | HK1169387A1 (es) |
IL (1) | IL217300A0 (es) |
MA (1) | MA33500B1 (es) |
MX (1) | MX2012000267A (es) |
MY (1) | MY155829A (es) |
NI (1) | NI201200001A (es) |
NZ (1) | NZ597578A (es) |
PE (1) | PE20120917A1 (es) |
SG (1) | SG177463A1 (es) |
TN (1) | TN2011000658A1 (es) |
TW (1) | TWI471312B (es) |
UA (1) | UA106500C2 (es) |
UY (1) | UY32757A (es) |
WO (1) | WO2011001122A2 (es) |
ZA (1) | ZA201200027B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2908409B1 (fr) * | 2006-11-10 | 2009-01-09 | Sanofi Aventis Sa | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
WO2013106432A1 (en) * | 2012-01-09 | 2013-07-18 | X-Rx, Inc. | Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof |
AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
CN106660997B (zh) | 2014-08-18 | 2019-05-21 | 卫材R&D管理有限公司 | 单环吡啶衍生物的盐及其晶体 |
CN107619388A (zh) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
CA3091153A1 (en) | 2018-03-28 | 2019-10-03 | Eisai R&D Management Co., Ltd. | Therapeutic agent for hepatocellular carcinoma |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331541B1 (en) * | 1998-12-18 | 2001-12-18 | Soo S. Ko | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
GB0317127D0 (en) * | 2003-07-22 | 2003-08-27 | Astex Technology Ltd | Pharmaceutical compounds |
MX2007008809A (es) * | 2005-01-21 | 2007-09-07 | Astex Therapeutics Ltd | Combinaciones de inhibidores de pirazol cinasa y otros agentes antitumor. |
JP5249776B2 (ja) * | 2005-12-02 | 2013-07-31 | バイエル・ヘルスケア・エルエルシー | 過剰増殖性疾患および血管新生と関連する疾患を処置するために有用な置換された4−アミノ−ピロロトリアジン誘導体 |
US20070197505A1 (en) * | 2005-12-15 | 2007-08-23 | Morgan Bradley P | Certain chemical entities, compositions and methods |
US20070208000A1 (en) * | 2005-12-15 | 2007-09-06 | Morgan Bradley P | Certain chemical entities, compositions and methods |
FR2908409B1 (fr) * | 2006-11-10 | 2009-01-09 | Sanofi Aventis Sa | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
WO2008073480A1 (en) * | 2006-12-11 | 2008-06-19 | Irm Llc | Compounds and compositions as kinase inhibitors |
-
2009
- 2009-07-03 FR FR0903270A patent/FR2947546B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-02 MA MA34592A patent/MA33500B1/fr unknown
- 2010-07-02 BR BR112012000104A patent/BR112012000104A2/pt not_active IP Right Cessation
- 2010-07-02 UY UY0001032757A patent/UY32757A/es not_active Application Discontinuation
- 2010-07-02 KR KR1020127002905A patent/KR20120037967A/ko not_active Application Discontinuation
- 2010-07-02 AU AU2010267824A patent/AU2010267824A1/en not_active Abandoned
- 2010-07-02 TW TW99121891A patent/TWI471312B/zh not_active IP Right Cessation
- 2010-07-02 EP EP10742179.4A patent/EP2448924B1/fr active Active
- 2010-07-02 NZ NZ597578A patent/NZ597578A/xx not_active IP Right Cessation
- 2010-07-02 AR ARP100102366A patent/AR077371A1/es unknown
- 2010-07-02 JP JP2012518123A patent/JP5680640B2/ja not_active Expired - Fee Related
- 2010-07-02 EA EA201270128A patent/EA020364B1/ru not_active IP Right Cessation
- 2010-07-02 MY MYPI2011006394A patent/MY155829A/en unknown
- 2010-07-02 SG SG2011097821A patent/SG177463A1/en unknown
- 2010-07-02 MX MX2012000267A patent/MX2012000267A/es active IP Right Grant
- 2010-07-02 CA CA2767096A patent/CA2767096A1/fr not_active Abandoned
- 2010-07-02 UA UAA201201093A patent/UA106500C2/uk unknown
- 2010-07-02 PE PE2012000008A patent/PE20120917A1/es not_active Application Discontinuation
- 2010-07-02 CN CN201080036552.8A patent/CN102471280B/zh not_active Expired - Fee Related
- 2010-07-02 WO PCT/FR2010/051394 patent/WO2011001122A2/fr active Application Filing
-
2011
- 2011-12-21 CR CR20110701A patent/CR20110701A/es unknown
- 2011-12-22 TN TNP2011000658A patent/TN2011000658A1/fr unknown
- 2011-12-23 US US13/336,253 patent/US8367715B2/en active Active
- 2011-12-29 IL IL217300A patent/IL217300A0/en unknown
-
2012
- 2012-01-02 DO DO2012000001A patent/DOP2012000001A/es unknown
- 2012-01-03 ZA ZA2012/00027A patent/ZA201200027B/en unknown
- 2012-01-03 CL CL2012000013A patent/CL2012000013A1/es unknown
- 2012-01-03 EC EC2012011569A patent/ECSP12011569A/es unknown
- 2012-01-03 CO CO12000505A patent/CO6480992A2/es active IP Right Grant
- 2012-01-03 EC ECSP12011659 patent/ECSP12011659A/es unknown
- 2012-01-05 NI NI201200001A patent/NI201200001A/es unknown
- 2012-10-08 HK HK12109827.6A patent/HK1169387A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018004124A2 (es) | Compuestos heterocíclicos | |
CO2018007528A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
ECSP19052302A (es) | Derivados de benzooxazol como inmunomoduladores | |
CL2018000542A1 (es) | Nuevos derivados de fenoximetilo. | |
CO2017011851A2 (es) | Compuestos novedosos | |
ECSP12011720A (es) | Compuestos heterocíclicos y usos de los mismos | |
NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
BR112016015838A8 (pt) | compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação | |
UY35485A (es) | Compuestos heterocíclicos y usos de los mismos | |
CL2012003415A1 (es) | Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer . | |
CL2010001538A1 (es) | Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de las proteinas quinasas; composicion farmaceutica; y su uso para el tratamiento del cancer, o un trastorno proliferativo celular. | |
CL2012000013A1 (es) | Compuestos derivados de 4-{3-[3-(4-trifluorometil-fenil)ureido]-5-fluoro-bencilamino}-1h-pirazol-3-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso como moduladores de la actividad de las proteinas quinasa para el tratamiento del cancer. | |
CL2016001895A1 (es) | Compuestos | |
ECSP20046463A (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas | |
CR20140161A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
CO7101245A2 (es) | Compuestos de benzaldehído sustituidos y métodos para su uso en incrementar la oxigenación del tejido | |
CL2014000746A1 (es) | Compuestos derivados de 3-pirimidin-4-il-oxazolidin-2-ona y sus sales, como inhibidores de las proteinas idh mutantes; composicion farmaceutica que los comprende, utiles para el tratamiento de trastornos de la proliferacion celular tal como el cancer. | |
CR20130588A (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace 2 | |
DOP2016000226A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
NI201300073A (es) | Compuestos y composiciones como inhibidores de la trk | |
CL2014001547A1 (es) | Compuestos derivados de benzotienilo-pirrolotriazina, como inhibidores de la proteina tirosina quinasa; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento y/o la prevencion de cancer y enfermedades tumorales. | |
ECSP13013048A (es) | Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores | |
ECSP13013024A (es) | 1,3-oxazinas como inhibidores de bace1 y/o bace2 | |
DOP2015000245A (es) | Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos | |
CL2015002608A1 (es) | Compuesto de amino-pirazol y usos medicinales relacionados. |